PHILADELPHIA– September 28, 2015 –– ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced enhancements to MasterScope, its comprehensive platform for spirometry, ECG, and home monitoring, especially designed for both standardized and centralized clinical trials.
MasterScope delivers an all-in-one solution that meets and exceeds the data collection and processing needs of worldwide clinical trial sponsors and Clinical Research Organizations (CROs) in the development of medical treatments for respiratory conditions such as Asthma and COPD – and in non-respiratory areas such as oncology and CNS to collect pulmonary safety and disease progression endpoints.
The enhanced version of MasterScope introduces unique features that optimize data quality, trial management, reduce costs and shorten timelines for pharmaceutical sponsors and CROs while boosting investigative site satisfaction and efficiency. The benefits of the new features, which are not yet available from other vendors include:
- Multi-protocol support minimizing equipment costs and logistics, speeding up trial initiation and also easing investigative site burden with fewer devices to set up, maintain and take up physical space at the site
- Wireless Local Area Network (Wi-Fi) and LAN connectivity with automatic, secure data transfers to optimize centralized overreads and device software updates, ensuring the latest protocol amendments are in use
“We listened closely to pharmaceutical sponsors and investigative site personnel to identify the MasterScope enhancements that would best meet their needs,” said Achim Schülke, Executive Vice President, Respiratory Solutions at ERT. “With the industry’s most flexible solution for true multi-protocol support, device reuse and the new data transfer options available, MasterScope continues to be the most advanced platform of its kind for cardiopulmonary diagnostics, helping sites and sponsors to achieve the highest data quality with ease of use, efficiency and cost effectiveness.”
ERT will demonstrate MasterScope and other innovative solutions in Booth 1.E_05 at the European Respiratory Society (ERS) International Congress, September 26-30, 2015 in Amsterdam, Netherlands.
ERT (https://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Switzerland, Japan and Germany. Join ERT on Facebook, LinkedIn, Twitter, and YouTube.